Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
08/2012
08/22/2012CN102643255A Andrographolide compound
08/22/2012CN102643248A Activating agent for peroxisome proliferator activated receptor
08/22/2012CN102641506A Bivalirudin-polyethylene glycol compound
08/22/2012CN102641480A Traditional Chinese medicine composite used for treating microcirculation disturbance and preparation method thereof
08/22/2012CN102641311A Kiwi fruit seed oil liposome oral liquid and preparation method thereof
08/22/2012CN102641259A Application of glaucocalyxin A in preparation of anticoagulation medicaments
08/22/2012CN102641254A Preparation method of aspirin enteric-coated sustained-release preparation
08/22/2012CN102641251A Underwater-dispersible tablet of Sevelamer carbonate
08/22/2012CN102640755A Insecticidal and acaricidal composition
08/22/2012CN102228620B Chinese medicinal compound preparation having the functions of supplementing iron and enriching the blood and preparation method thereof
08/22/2012CN102166329B Medicine for treating leukopenia caused by chronic hepatitis B or interferon and preparation method thereof
08/22/2012CN102085332B Medicament for treating early ascites due to cirrhosis
08/22/2012CN102040667B Method for biologically removing protein from sea cucumber polysaccharide
08/22/2012CN101948439B Extraction method and application to medicine of active alkaloid compounds in cervus nippon temminck
08/22/2012CN101842093B PAI-1 production inhibitor
08/22/2012CN101773489B Application of citric acid diethyl ester in preparation of anticoagulant medicament
08/22/2012CN101653511B Edible bird's nest and ddonkey-hide gelatin oral liquid
08/22/2012CN101485751B Cotinus coggygria compound preparation and use
08/21/2012US8247562 Benzamide derivatives useful as histone deacetylase inhibitors
08/21/2012US8247407 Pharmaceutical composition with anti-diabetic action
08/21/2012US8246958 Methods of inhibiting alpha-4-dependent interactions with VCAM-1 with anti-VLA-4 antibodies
08/21/2012US8246930 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
08/21/2012CA2688047C Composition of biocompatible microparticles of alginic acid for the controlled release of active ingredients by intravenous administration
08/21/2012CA2540370C Novel thioxylose compounds, preparation method thereof, pharmaceutical compositions containing same and use thereof in therapeutics
08/21/2012CA2288143C Activated protein c formulations
08/16/2012WO2012109065A2 Treatment and prevention of cardiovascular disease and thrombosis
08/16/2012WO2012107402A1 Idrabiotaparinux for the treatment of pulmonary embolism and for the secondary prevention of venous thromboembolic events
08/16/2012WO2012071561A3 Anti-il-6 antibodies for the treatment of anemia
08/16/2012US20120209050 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
08/16/2012US20120208993 Synthetic heparin trisaccharides
08/16/2012US20120208854 Therapeutic combination
08/16/2012US20120208852 Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
08/16/2012US20120208837 Substituted azaindoles
08/16/2012US20120208805 Triazolium salts as par1 inhibitors, production thereof, and use as medicaments
08/16/2012US20120208793 Thieno- and furo-pyrimidine modulators of the histamine h4 receptor
08/16/2012US20120208785 Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
08/16/2012US20120208777 Diosmetin compounds, a process for their preparation and pharmaceutical compositions containing them
08/16/2012US20120208774 Method for inhibiting "melanoma inhibitory activity" mia
08/16/2012US20120208772 Cytokine zalpha11 ligand
08/16/2012US20120208761 Type i-type iv collagen hybrid gel
08/16/2012US20120208760 Thrombopoietic compounds
08/16/2012US20120207825 Pharmaceutical compositions for reducing alcohol-induced dose dumping
08/16/2012US20120207822 Compositions and methods for treatment of cardiovascular disease
08/16/2012US20120207813 Rapidly acting dry sealant and methods for use and manufacture
08/16/2012US20120207791 Immobilized biologically active entities having a high degree of biological activity
08/16/2012US20120207749 Dosing regimen
08/16/2012US20120207730 Methods and Compositions for Treating Viral Hemorrhagic Fever
08/16/2012US20120207725 Mesenchymal stem cell incorporating a nucleotide sequence coding tgfb, and uses thereof
08/16/2012US20120207713 Probiotic bifidobacterium strains
08/16/2012US20120207704 Inhibiting Aberrant Blood Vessel Formation Using Growth Factor Retargeted Endopeptidases
08/16/2012CA2826972A1 Treatment and prevention of cardiovascular disease and thrombosis
08/15/2012EP2486936A1 A composition comprising VWF and FVIII preparations for use in treating of bleeding disorders
08/15/2012EP2297159B1 Substituted quinazolines
08/15/2012EP2238127B1 Pyrazole-carboxamide derivatives as p2y12 antagonists
08/15/2012EP2167117B1 Use of vwf stabilized fviii preparations for extravascular administration in the therapy and prophylactic treatment of bleeding disorders
08/15/2012EP1894567B1 Concomitant pharmaceutical agents and use thereof
08/15/2012EP1438295B1 Azole derivatives and pharmaceutical compositions containing them
08/15/2012EP1294391B1 Combination of agents for inhibiting transplant rejection
08/15/2012CN1895264B Medicinal use of quercetin-3-0-beta-D-glucancoside
08/15/2012CN102639553A Method of purifying pegylated proteins
08/15/2012CN102639518A Novel phenol derivative
08/15/2012CN102634479A Cell protective agent containing metallothionein
08/15/2012CN102633908A Method for preparing high-quality LMW (low molecular weight) heparins
08/15/2012CN102633904A Hydrolysis technology for protease of heparin sodium
08/15/2012CN102633893A Hypo- and hyper-acetylated meningococcal capsular saccharides
08/15/2012CN102633832A Method for preparing high-purity phosphatidylcholine
08/15/2012CN102633780A Nitric oxide donor with thrombin inhibition effect, as well as preparation method and medical application thereof
08/15/2012CN102633777A Dabigatran etexilate 2-ketoglutarate as well as preparation method and application thereof
08/15/2012CN102631591A Method for preparing traditional Chinese medicine (TCM) for treating edema type colitis
08/15/2012CN102631584A Chinese medicinal composition for treating idiopathic thrombocytopenic purpura
08/15/2012CN102631572A Method for preparing traditional Chinese medicine (TCM) lotion for treating hemorrhagic pustule on sole
08/15/2012CN102631470A Ejiao Guiqi granules and manufacturing method thereof
08/15/2012CN102631441A Separation and purification method of total saponins of sanguisorba officinalis
08/15/2012CN102631426A Traditional Chinese medicine composition for treating anaphylactoid purpura
08/15/2012CN102631417A Traditional Chinese medicine extract for haemostasis and preparation method thereof
08/15/2012CN102631403A Method for preparing total matrines
08/15/2012CN102631402A Astragalus mongholicus injection and preparation process thereof
08/15/2012CN102631376A Medicament for treating epistaxis
08/15/2012CN102631369A Application of bone marrow mesenchymal stem cells (MSCs) to preparation of drugs for treating autoimmune diseases
08/15/2012CN102631359A Application of ginsenoside with chemical structure for preparing medicine used for preventing and/ or treating thrombus
08/15/2012CN102631337A Application of coenzyme Q10 to preparation of medicines for preventing and treating altitude erythrocytosis
08/15/2012CN102631336A Freeze-drying orally disintegrating tablet with vitamin K1 composition for infants and preparation method for freeze-drying orally disintegrating tablet
08/15/2012CN102631328A Recombinant human antithrombosis protein lyophilized powder injection and preparation method thereof
08/15/2012CN102631320A Betahistine hydrochloride liposome and preparation method thereof
08/15/2012CN102630943A Spirulina gamma-linolenic acid extractive and preparation method thereof
08/15/2012CN101304979B Quinazoline derivative and pharmaceutical
08/15/2012CN101066303B Medicine for treating cerebral thrombus, cerebral angiosclerosis, apoplexy and hemiplegia and its preparation
08/14/2012US8242147 Aryl ureas with angiogenisis inhibiting activity
08/14/2012US8242098 Methods of treating hormone-related conditions using thio-oxindole derivatives
08/14/2012US8242091 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1; peroxiredoxin
08/14/2012US8241668 Polymers contqining ester, thioester or amide groups in backbone which degrade into bioactive material upon hydrolysis
08/14/2012US8241665 Chewable soft capsule
08/14/2012CA2520628C T-type calcium channel blocker
08/14/2012CA2497845C Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols
08/14/2012CA2452075C Sustained release delivery system
08/14/2012CA2404679C Adenine binding g-protein coupled receptors
08/09/2012WO2012104638A1 Therapeutic agents with improved fibrinogen binding
08/09/2012WO2012103807A1 Bifunctional anti-platelet aggregation medicament and uses thereof
08/09/2012US20120202876 Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
08/09/2012US20120202857 Novel salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents
1 ... 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 ... 671